Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

77 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Inhibitors of indoleamine-2,3-dioxygenase for cancer therapy: can we see the wood for the trees?
Löb S, Königsrainer A, Rammensee HG, Opelz G, Terness P. Löb S, et al. Nat Rev Cancer. 2009 Jun;9(6):445-52. doi: 10.1038/nrc2639. Nat Rev Cancer. 2009. PMID: 19461669 Review.
Are indoleamine-2,3-dioxygenase producing human dendritic cells a tool for suppression of allogeneic T-cell responses?
Löb S, Ebner S, Wagner S, Weinreich J, Schäfer R, Königsrainer A. Löb S, et al. Transplantation. 2007 Feb 27;83(4):468-73. doi: 10.1097/01.tp.0000251646.09702.ec. Transplantation. 2007. PMID: 17318080
Levo- but not dextro-1-methyl tryptophan abrogates the IDO activity of human dendritic cells.
Lob S, Konigsrainer A, Schafer R, Rammensee HG, Opelz G, Terness P. Lob S, et al. Blood. 2008 Feb 15;111(4):2152-4. doi: 10.1182/blood-2007-10-116111. Epub 2007 Nov 28. Blood. 2008. PMID: 18045970
Is IDO a key enzyme bridging the gap between tumor escape and tolerance induction?
Löb S, Königsrainer A. Löb S, et al. Langenbecks Arch Surg. 2008 Nov;393(6):995-1003. doi: 10.1007/s00423-007-0245-7. Epub 2007 Dec 4. Langenbecks Arch Surg. 2008. PMID: 18064486 Review.
IDO1 and IDO2 are expressed in human tumors: levo- but not dextro-1-methyl tryptophan inhibits tryptophan catabolism.
Löb S, Königsrainer A, Zieker D, Brücher BL, Rammensee HG, Opelz G, Terness P. Löb S, et al. Cancer Immunol Immunother. 2009 Jan;58(1):153-7. doi: 10.1007/s00262-008-0513-6. Epub 2008 Apr 17. Cancer Immunol Immunother. 2009. PMID: 18418598
Role of IDO in organ transplantation: promises and difficulties.
Löb S, Königsrainer A. Löb S, et al. Int Rev Immunol. 2009;28(3-4):185-206. doi: 10.1080/08830180902989119. Int Rev Immunol. 2009. PMID: 19811321 Review.
Prognostic value of tumour-infiltrating CD8+ lymphocytes in rectal cancer after neoadjuvant chemoradiation: is indoleamine-2,3-dioxygenase (IDO1) a friend or foe?
Schollbach J, Kircher S, Wiegering A, Seyfried F, Klein I, Rosenwald A, Germer CT, Löb S. Schollbach J, et al. Among authors: lob s. Cancer Immunol Immunother. 2019 Apr;68(4):563-575. doi: 10.1007/s00262-019-02306-y. Epub 2019 Jan 22. Cancer Immunol Immunother. 2019. PMID: 30671614
Rapamycin-induced impaired wound healing is associated with compromised tissue lactate accumulation and extracellular matrix remodeling.
Weinreich J, Löb S, Löffler M, Königsrainer I, Zieker D, Königsrainer A, Coerper S, Beckert S. Weinreich J, et al. Among authors: lob s. Eur Surg Res. 2011;47(1):39-44. doi: 10.1159/000327972. Epub 2011 May 20. Eur Surg Res. 2011. PMID: 21597297
Morbid obesity and subsequent pancreatic cancer: pylorus-preserving pancreatoduodenectomy after laparoscopic sleeve gastrectomy.
Küper MA, Königsrainer I, Schmidt D, Kramer KM, Granderath FA, Schneider J, Löb S, Zieker D, Hartmann JT, Zdichavsky M, Königsrainer A, Brücher BL. Küper MA, et al. Among authors: lob s. Obes Surg. 2009 Mar;19(3):385-8. doi: 10.1007/s11695-008-9679-4. Epub 2008 Sep 25. Obes Surg. 2009. PMID: 18815848
Surgery of colorectal carcinoma in patients aged over 80.
Falch C, Kratt T, Beckert S, Kirschniak A, Zieker D, Königsrainer I, Löb S, Hartmann JT, Königsrainer A, Brücher BL. Falch C, et al. Among authors: lob s. Onkologie. 2009 Feb;32(1-2):10-6. doi: 10.1159/000184580. Epub 2009 Jan 20. Onkologie. 2009. PMID: 19209013
77 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback